• About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Board
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • Fimepinostat
    • CA-170
    • CA-327
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
      • Historical Stock Lookup
      • Analyst Coverage
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact
  • About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Board
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Studies Now Enrolling
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • Fimepinostat
    • CA-170
    • CA-327
  • Scientific Resources
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact

IRS Form 8937

2026 Reverse Stock Split
Download IRS Form 8937

Download IRS Form 8937
July 8, 2026 (159 KB)
 
2023 Reverse Stock Split
Download IRS Form 8937

Download IRS Form 8937
November 8, 2023 (1.5 MB)
 
© Curis, Inc. 2026 - All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Board
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • Fimepinostat
    • CA-170
    • CA-327
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact